iTeos Therapeutics, Inc. (ITOS) Tops Q1 EPS by 13c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q1 EPS of ($0.80), $0.13 better than the analyst estimate of ($0.93).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• McEwen Copper seeks $1.6b in equity financing for Los Azules - Bloomberg
• Taylor Devices (TAYD) Misses Q4 EPS by 31c
• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%